Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.7.0.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2017
Mar. 31, 2016
Costs and Expenses:    
Research and development $ 89,600 $ 36,450
General and administrative 617,537 508,890
Loss from operations (707,137) (545,340)
Interest expense (including $58,142 and $53,944 to related parties) (84,005) (72,570)
Interest expense - amortization of debt discount (39,678) (79,370)
Loss from extinguishment of accounts payable (26,000)
Net loss $ (856,820) $ (697,280)
Earnings per share - basic and diluted $ (0.01) $ (0.01)
Weighted average number of common shares outstanding - basic and diluted 95,882,696 63,859,000